Hepatitis C Treatment by Early-Career US Family Physicians

The authors aimed to assess the extent to which early-career family physicians in the U.S. provide treatment for hepatitis C, given the low treatment rates despite the availability of effective therapies. Their findings revealed that less than 20% of these physicians reported treating HCV patients, with notable variations based on physician characteristics and practice settings, particularly in areas with higher HCV mortality. The study suggests that enhancing support for family physicians could improve HCV treatment rates, especially in underserved regions.